Hypergrowth mTORC1 Signals Translationally Activate the ARF Tumor Suppressor Checkpoint

被引:18
作者
Miceli, Alexander P.
Saporita, Anthony J.
Weber, Jason D. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Internal Med, BRIGHT Inst,Div Mol Oncol, St Louis, MO 63110 USA
关键词
TUBEROUS SCLEROSIS COMPLEX; MESSENGER-RNA TRANSLATION; CELL-CYCLE CHECKPOINTS; GENE-EXPRESSION; P53-DEPENDENT APOPTOSIS; MAMMALIAN TARGET; DNA-DAMAGE; PROTEIN; P53; P19(ARF);
D O I
10.1128/MCB.06030-11
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ARF tumor suppressor is a potent sensor of hyperproliferative cues emanating from oncogenic signaling. ARF responds to these cues by eliciting a cell cycle arrest, effectively abating the tumorigenic potential of these stimuli. Prior reports have demonstrated that oncogenic Ras(v12) signaling induces ARF through a mechanism mediated by the Dmp1 transcription factor. However, we now show that ARF protein is still induced in response to Ras(v12) in the absence of Dmp1 through the enhanced translation of existing Arf mRNAs. Here, we report that the progrowth Ras/tuberous sclerosis complex (TSC)/mTORC1 signaling pathway regulates ARF protein expression and triggers ARF-mediated tumor suppression through a novel translational mechanism. Hyperactivation of mTORC1 through Tsc1 loss resulted in a significant increase in ARF expression, activation of the p53 pathway, and a dramatic cell cycle arrest, which were completely reversed upon Arf deletion. ARF protein induced from Ras(v12) in the absence of Dmp1 repressed anchorage-independent colony formation in soft agar and tumor burden in an allograft model. Taken together, our data demonstrate the ability of the ARF tumor suppressor to respond to hypergrowth stimuli to prevent unwarranted tumor formation.
引用
收藏
页码:348 / 364
页数:17
相关论文
共 55 条
[1]   A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function [J].
Apicelli, Anthony J. ;
Maggi, Leonard B., Jr. ;
Hirbe, Angela C. ;
Miceli, Alexander P. ;
Olanich, Mary E. ;
Schulte-Winkeler, Crystal L. ;
Saporita, Anthony J. ;
Kuchenreuther, Michael ;
Sanchez, Jose ;
Weilbaecher, Katherine ;
Weber, Jason D. .
MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (03) :1068-1080
[2]   MECHANISM OF PUROMYCIN ACTION - FATE OF RIBOSOMES AFTER RELEASE OF NASCENT PROTEIN CHAINS FROM POLYSOMES [J].
AZZAM, ME ;
ALGRANATI, ID .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (12) :3866-3869
[3]   p14ARF links the tumour suppressors RB and p53 [J].
Bates, S ;
Phillips, AC ;
Clark, PA ;
Stott, F ;
Peters, G ;
Ludwig, RL ;
Vousden, KH .
NATURE, 1998, 395 (6698) :124-125
[4]   ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway [J].
Brady, SN ;
Yu, Y ;
Maggi, LB ;
Weber, JD .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (21) :9327-9338
[5]   5′-3′-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage [J].
Chen, Jing ;
Kastan, Michael B. .
GENES & DEVELOPMENT, 2010, 24 (19) :2146-2156
[6]   The tuberous sclerosis complex [J].
Crino, Peter B. ;
Nathanson, Katherine L. ;
Henske, Elizabeth Petri .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (13) :1345-1356
[7]   New Insights into Checkpoint Kinase 1 in the DNA Damage Response Signaling Network [J].
Dai, Yun ;
Grant, Steven .
CLINICAL CANCER RESEARCH, 2010, 16 (02) :376-383
[8]   E1A signaling to p53 involves the p19ARF tumor suppressor [J].
de Stanchina, E ;
McCurrach, ME ;
Zindy, F ;
Shieh, SY ;
Ferbeyre, G ;
Samuelson, AV ;
Prives, C ;
Roussel, MF ;
Sherr, CJ ;
Lowe, SW .
GENES & DEVELOPMENT, 1998, 12 (15) :2434-2442
[9]   Cell cycle checkpoints: Preventing an identity crisis [J].
Elledge, SJ .
SCIENCE, 1996, 274 (5293) :1664-1672
[10]   Igbp1 is part of a positive feedback loop in stem cell factor-dependent, selective mRNA translation initiation inhibiting erythroid differentiation [J].
Grech, Godfrey ;
Blazquez-Domingo, Montserrat ;
Kolbus, Andrea ;
Bakker, Walbert J. ;
Muellner, Ernst W. ;
Beug, Hartmut ;
von Lindern, Marieke .
BLOOD, 2008, 112 (07) :2750-2760